Видео ютуба по тегу Sanofi-Genzyme

Spirit of Hope - A History of Genzyme 1981-2012
Spirit of Hope - A History of Genzyme 1981-2012
Sanofi Genzyme Rare Disease Day 2017
Sanofi Genzyme Rare Disease Day 2017
Sanofi Agrees to Acquire Genzyme for $20.1 Billion
Sanofi Agrees to Acquire Genzyme for $20.1 Billion
Sobi and Sanofi Genzyme: Partnership is helping to provide access to hemophilia treatment worldwide
Sobi and Sanofi Genzyme: Partnership is helping to provide access to hemophilia treatment worldwide
Genzyme: répondre aux besoins des patients atteints de maladies rares
Genzyme: répondre aux besoins des patients atteints de maladies rares
Sanofi Genzyme - Humanitarian Aid Program to Treat Rare Diseases
Sanofi Genzyme - Humanitarian Aid Program to Treat Rare Diseases
Careers in Biopharma: Working on the future with Sanofi Genzyme
Careers in Biopharma: Working on the future with Sanofi Genzyme
video 6. Acquisition. Sanofi and Genzyme business case. Genzyme company situation.
video 6. Acquisition. Sanofi and Genzyme business case. Genzyme company situation.
Jean-Paul Scheur, General Manager of Sanofi Genzyme
Jean-Paul Scheur, General Manager of Sanofi Genzyme
Sanofi Genzyme et Sobi : un partenariat pour favoriser l’accès aux traitements contre l’hémophilie
Sanofi Genzyme et Sobi : un partenariat pour favoriser l’accès aux traitements contre l’hémophilie
Genzyme, Sanofi CEOs talk about finalized merger
Genzyme, Sanofi CEOs talk about finalized merger
Sanofi Genzyme 2021 TORCH Awards
Sanofi Genzyme 2021 TORCH Awards
Sanofi Genzyme 2020 TORCH Awards
Sanofi Genzyme 2020 TORCH Awards
Genzyme / Sanofi : $75-80 per share, The Big Win-Win
Genzyme / Sanofi : $75-80 per share, The Big Win-Win
Energy-Flow Jewelry Questioned; Sanofi's Genzyme Bid: Video
Energy-Flow Jewelry Questioned; Sanofi's Genzyme Bid: Video
Rare Diseases - Sanofi Genzyme Europe
Rare Diseases - Sanofi Genzyme Europe
BioProcess International 2014 Interview: Bob Mattaliano, Sanofi Genzyme R&D Center
BioProcess International 2014 Interview: Bob Mattaliano, Sanofi Genzyme R&D Center
Comte Says Sanofi Will Be Able to Retain Genzyme Talent
Comte Says Sanofi Will Be Able to Retain Genzyme Talent